entertainment -WSS

entertainment

author：focus 2025-09-06 01:57:29 - browse：185

Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Walmart eyes Medicare Advantage provider ChenMed

WSS

GSK Flovent asthma inhalers replaced by authorized generics

How medical schools plan to diversify without affirmative action

White House touts steps to stem shortages of cancer treatments

Regeneron agrees to White House price limits on anti

FDA approves updated Covid vaccines

Walmart eyes Medicare Advantage provider ChenMed

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Walensky prepares to leave CDC — and Congress — behind

New weight loss drugs vying to be the next Wegovy or Mounjaro

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Affirmative action in medical school literally saved lives

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Jerome Adams on the need for new antivirals for Covid

Goldman Sachs launches $650M fund for life science investments

Guidelines to prevent youth baseball injuries need more muscle

Antibiotic resistance and the global rise in human conflict

leisure time

U.K. sequencing study surfaces new findings about tumor DNA

GSK Flovent asthma inhalers replaced by authorized generics

Diverse clinical trials: Why aren’t we there yet?

White House touts steps to stem shortages of cancer treatments

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Goldman Sachs launches $650M fund for life science investments

hotspot

knowledge

hotspot

focus